Health Care Professionals
For Healthcare Professionals
Alivora Therapeutics is a biopharmaceutical company focused on the development of cannabinoid-based therapeutics for pain and complex neurological disorders, including Multiple Sclerosis (MS) and Huntington’s Disease (HD). Our lead formulation—a pharmaceutical-grade softgel capsule derived from natural plant compounds—is designed to deliver precise, consistent dosing with therapeutic potential backed by science.
We have submitted multiple Investigational New Drug (IND) applications to the U.S. FDA and are actively engaged in pursuing regulatory approvals worldwide. To support clinical integration and regulatory transparency, we provide comprehensive product dossiers, physician education kits, and ongoing scientific updates.
In collaboration with leading physicians and clinical researchers, we are committed to:
- Advancing the scientific understanding of cannabinoid pharmacology
- Maintaining strict adherence to cGMP manufacturing standards
- Developing safe, effective, and evidence-based cannabinoid therapies for patients with serious unmet needs